baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BioMarin Pharmaceutical/ US09061G1013 /

2024-11-12 9:59:56 PM	Chg. -0.21	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
66.13USD	-0.32%	56,424 Turnover: 3.74 mill.	-Bid Size: -	-Ask Size: -	12.6 bill.USD	-	74.30

GlobeNewswire 07-26 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 07-20 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 07-12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 07-07 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 06-30 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharm...

GlobeNewswire 06-28 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease

GlobeNewswire 06-22 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 06-13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 06-05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 05-28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 05-08 Terns Pharmaceuticals Announces Leadership Changes

GlobeNewswire 2023-11-02 California Life Sciences announces 20th annual Pantheon Award winners

GlobeNewswire 2023-10-02 California’s top scientific innovators selected as finalists for the 20th annual California Life Sci...

GlobeNewswire 2022-03-01 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...

GlobeNewswire 2022-02-14 Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

Newsfile Corp 2022-02-04 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 2022-01-24 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 2021-12-23 Lifshitz Law Firm, P.C. Announces Investigations of Amarin Corporation plc (NASDAQGM: AMRN), BioMari...

GlobeNewswire 2021-12-21 BMRN FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioMarin Pharmaceutical Inc....

GlobeNewswire 2021-12-20 BMRN & RECAF – Upcoming Lead Deadlines: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2021-12-20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-12-17 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure C...

GlobeNewswire 2021-12-07 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-12-07 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Befor...

GlobeNewswire 2021-12-01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

BioMarin Pharmaceutical/ US09061G1013 /

If you wish to receive reply to your feedback, please provide your email address.